Table 1. L-BMAA administration prolonged motor-evoked potential (MEP) latency and lowered MEP amplitude.

Time point	Group	Latency (ms)	Wave amplitude (μV)
2 weeks	Normal	2.1±0.5**	3.6±0.21**
	Vehicle	6.6±0.31	0.2±0.16
	C+A	5.35±0.28*	1.2±0.25**
	L-ser	4.26±0.3**	2.26±0.11**
	Combined	4.9±0.55**	3.7±0.21**
4 weeks	Vehicle	7.1±0.65	0.2±0.18
	C+A	4.6±0.42**	3.0±0.78**
	L-ser	4.22±0.10**	2.2±0.42**
	Combined	4.19±0.68**	4.6±0.43**
8 weeks	Vehicle	7.3±0.5	0.2±0.08
	C+A	2.3±0.12**	2.0±0.28*
	L-ser	4.2±0.9**	3.67±0.32**
	Combined	4.35±0.18**	4.75±0.55**

C+A, C16+Ang-1; L-ser, L-serine; combined, C16+Ang-1 and L-serine. Data are expressed as mean±SD, n=5. *p<0.05 and **p<0.01 vs. the vehicle group (one-way ANOVA).